chr2-162173765-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_004460.5(FAP):​c.1992C>A​(p.Phe664Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000241 in 1,452,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

FAP
NM_004460.5 missense

Scores

2
10
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.92

Publications

0 publications found
Variant links:
Genes affected
FAP (HGNC:3590): (fibroblast activation protein alpha) The protein encoded by this gene is a homodimeric integral membrane gelatinase belonging to the serine protease family. It is selectively expressed in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas. This protein is thought to be involved in the control of fibroblast growth or epithelial-mesenchymal interactions during development, tissue repair, and epithelial carcinogenesis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.845

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAPNM_004460.5 linkc.1992C>A p.Phe664Leu missense_variant Exon 23 of 26 ENST00000188790.9 NP_004451.2 Q12884-1
FAPNM_001291807.3 linkc.1917C>A p.Phe639Leu missense_variant Exon 22 of 25 NP_001278736.1 Q12884B4DLR2
FAPXM_011510796.4 linkc.1962C>A p.Phe654Leu missense_variant Exon 22 of 25 XP_011509098.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAPENST00000188790.9 linkc.1992C>A p.Phe664Leu missense_variant Exon 23 of 26 1 NM_004460.5 ENSP00000188790.4 Q12884-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000797
AC:
2
AN:
250876
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000241
AC:
35
AN:
1452002
Hom.:
0
Cov.:
27
AF XY:
0.0000235
AC XY:
17
AN XY:
722984
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33244
American (AMR)
AF:
0.00
AC:
0
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26030
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39606
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86000
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
0.0000308
AC:
34
AN:
1103286
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 26, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1992C>A (p.F664L) alteration is located in exon 23 (coding exon 23) of the FAP gene. This alteration results from a C to A substitution at nucleotide position 1992, causing the phenylalanine (F) at amino acid position 664 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Uncertain
0.017
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.43
.;T;.
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.88
D;D;D
M_CAP
Benign
0.023
T
MetaRNN
Pathogenic
0.84
D;D;D
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.2
.;L;.
PhyloP100
3.9
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-3.5
.;D;D
REVEL
Benign
0.23
Sift
Benign
0.063
.;T;T
Sift4G
Uncertain
0.0080
D;D;D
Polyphen
0.45, 0.45
.;P;B
Vest4
0.83
MutPred
0.89
.;Gain of disorder (P = 0.1163);.;
MVP
0.46
MPC
0.13
ClinPred
0.72
D
GERP RS
5.0
Varity_R
0.61
gMVP
0.52
Mutation Taster
=49/51
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1450977209; hg19: chr2-163030275; COSMIC: COSV99502213; COSMIC: COSV99502213; API